Who owns the ROLVEDON trademark?

The ROLVEDON trademark is owned by Spectrum Pharmaceuticals, Inc..

What class is the ROLVEDON trademark registered in?

The ROLVEDON trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ROLVEDON?

The USPTO serial number for ROLVEDON is 97211650.

What is the registration number for ROLVEDON?

ROLVEDON is registered under USPTO registration number 7050504.

Sealvo

Home Search: ROLVEDONROLVEDON #97211650

Back

Updated Oct 8, 2026·16 searches this week

View on USPTO TSDR Find similar marks

ROL

USPTO Trademark Record

REGISTERED

ROLVEDON

SN 97211650·Reg 7050504·Filed Jan 10, 2022

Owner Spectrum Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ROLVEDON (Serial No. 97211650), Registration No. 7050504, is a registered US trademark filed on Jan 10, 2022 by Spectrum Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 09, 2029

Mark Intelligence

ROLVEDON (Reg. #7050504) is a registered US trademark that has been protecting its owner, Spectrum Pharmaceuticals, Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 10, 2022

SERIAL

97211650

REG#

7050504

REGISTERED

May 09, 2023

Filing Information

StatusREGISTERED

Filing DateJan 10, 2022

Serial Number97211650

Registration No.7050504

Registration DateMay 09, 2023

Status DateMay 09, 2023

Published for OppositionAug 16, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1676224

480Jul 08, 2022

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 17, 2022

First use in commerce: Oct 17, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 17, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 17, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 17, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 17, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 17, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Aug 09, 2023

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED-PRINCIPAL REGISTER

May 09, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 09, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 06, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 05, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 03, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 03, 2023

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Mar 16, 2023

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Mar 16, 2023

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 11, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 16, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 16, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 27, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 09, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 08, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 18, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 13, 2022

NEW APPLICATION ENTERED

Other Marks by Spectrum Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

ACC

ACCESS4ME

97399084

Spectrum Pharmaceuticals, Inc.

REGISTERED

STA

STAR

77472180

Spectrum Pharmaceuticals, Inc.

REGISTERED

SPE

SPECTRUM PHARMACEUTICALS, INC.

78814836

Spectrum Pharmaceuticals, Inc.

REGISTERED

POZ

POZENVEO

97060082

Spectrum Pharmaceuticals, Inc.

ABANDONED

Other Marks by Tim Burgdorf

Additional USPTO filings handled by the same attorney of record.

ASS

ASSERTIO SPECIALTY PHARMACEUTICALS

99084137

REGISTERED

REN

RENEWAL WATCH

99537185

REGISTERED

DOC

DOCUMENT SHIELD

99537172

REGISTERED

GOV

GOV+

99557445

REGISTERED

ROLVEDON

Run a conflict check

Other Marks by Spectrum Pharmaceuticals, Inc.

Other Marks by Tim Burgdorf

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company